x
Filter:
Filters applied
- Congenital: Fontan
- Research ArticleRemove Research Article filter
- Cordina, RachaelRemove Cordina, Rachael filter
- Attard, ChantalRemove Attard, Chantal filter
Publication Date
Please choose a date range between 2021 and 2021.
Keyword
- ANZ1
- aspirin1
- Australia and New Zealand1
- BMD1
- bone density1
- bone mineral density1
- CI1
- confidence interval1
- dual-energy X-ray absorptiometry1
- DXA1
- Fontan1
- INR1
- international normalized ratio1
- magnetic resonance imaging1
- MRI1
- odds ratio1
- OR1
- Pediatric Quality of Life Inventory1
- PedsQL1
- QoL1
- quality of life1
- REDCap1
- Research Electronic Data Capture1
- WA-BAT1
- Warfarin and Aspirin Bleeding assessment tool1
Congenital: Fontan
1 Results
- Congenital: Fontan
Long-term outcomes of warfarin versus aspirin after Fontan surgery
The Journal of Thoracic and Cardiovascular SurgeryVol. 162Issue 4p1218–1228.e3Published online: January 4, 2021- Chantal Attard
- Paul T. Monagle
- Yves d'Udekem
- Mark T. Mackay
- Julie Briody
- Rachael Cordina
- and others
Cited in Scopus: 11Because of the nature of the Fontan physiology, patients are at an increased risk of thromboembolic complications. As such, warfarin or aspirin is generally prescribed lifelong for thromboprophylaxis. This study aimed to compare long-term rates of cerebrovascular injury, thrombosis, bleeding, bone mineral density, and quality of life in people living with Fontan circulation receiving warfarin compared with aspirin.